Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$58.53T
24h Vol:
$9.62B
Dominance:
MSFT:5.17%
Stocklytics Platform
BETA
Instrument logo  BSX

Boston Scientific Corp

BSX
71 / 100
S&P500
$66.67arrow_drop_down-0.49%-$0.33
Key Stats
Open$67.03
Prev. Close$67.00
EPS1.07
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$98.63B
PE Ratio62.75
LOWHIGH
Day Range66.95
67.25
52 Week Range46.20
67.32
Ratios
P/B Ratio5.10
Revenue$14.24B
Operating M. %16.56%
Earnings$1.59B
Earnings Growth %128.08%
EBITDA Margin %25.37%
ROE %8.58%
EPS1.07
Fundamentals
RPS$9.80
Gross Profit$9.89B
EBITDA$3.61B
Total Debt$9.56B
P/S Ratio6.9x
Enterprise to EBITDA31.03
Profit Margin11.18%
ROA4.47%
Debt/Equity Ratio0.49%
Payout Ratio-
Industry average yield3.02%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

BSXarrow_drop_up0.21%
US Healthcare Sectorarrow_drop_up0.46%
US Marketarrow_drop_up2.14%
BSX / Market
BSX lose to the US Market which returned 2.14% over the last twenty four hours.
BSX / Healthcare Sector
BSX lose to the US Healthcare sector which returned 0.46% over the last twenty four hours.

Boston Scientific Corp (BSX) Statistics

Boston Scientific Corp (BSX) is a company engaged in the development, manufacture, and marketing of medical devices. As of the latest statistics, the stock of Boston Scientific Corp is traded on the stock exchange under the ticker symbol BSX. Investors and analysts often evaluate the valuation metrics of the company to determine its fair value. These metrics provide insights into the relative value of the stock compared to its peers and the overall market. Some of the commonly analyzed valuation metrics include price to earnings ratio, price to sales ratio, and price to book ratio.

In terms of fundamentals, Boston Scientific Corp has a strong financial position. The company consistently generates revenue and has a positive profit margin. The stock performance of Boston Scientific Corp is also compared with its sector to assess its relative performance. This comparison helps investors understand whether the stock is outperforming or lagging behind its industry peers. Additionally, Boston Scientific Corp's stock revenue per share indicates the portion of revenue allocated to each outstanding share. This metric provides insights into the revenue generation efficiency of the company.

add Boston Scientific Corp to watchlist

Keep an eye on Boston Scientific Corp

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
How has Boston Scientific Corp (BSX) stock's performance compared to its sector and the market over the past year?

Over the past year, Boston Scientific Corp (BSX) has experienced a price change of 43.43%. Compared to the Healthcare sector, which saw a change of 37.83%, Boston Scientific Corp has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 39.07%, it has fallen short of the market average. This comparison highlights Boston Scientific Corp's performance relative to both its sector and the overall market over the last year.

question_mark
What is the PE ratio of Boston Scientific Corp (BSX) stock?

The PE (Price to Earnings) ratio of Boston Scientific Corp (BSX) is currently 62.75. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.

question_mark
What is the EPS of Boston Scientific Corp (BSX) stock?

The Earnings Per Share (EPS) for Boston Scientific Corp (BSX), calculated on a diluted basis, is $1.07. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

question_mark
What is the operating margin of Boston Scientific Corp (BSX) stock?

The operating margin for Boston Scientific Corp (BSX) is 16.56%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

question_mark
What is the EBITDA of Boston Scientific Corp (BSX) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Boston Scientific Corp (BSX) is $3.62B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

question_mark
How much debt does Boston Scientific Corp (BSX) have?

Boston Scientific Corp (BSX) has a total debt of $9.57B. The net debt, which accounts for cash and cash equivalents against the total debt, is $8.63B.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.